Cyclobenzaprine hydrochloride
- Product NDC
- 50090-5756
- 11-digit product format
- 500905756
- Labeler code
- 50090
- Product ID
- 50090-5756_26f5cef8-35eb-4cc3-b7b4-7f48b1e3526c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA213324
- Marketing category
- ANDA
- Marketing start
- 2020-07-06
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cyclobenzaprine hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CYCLOBENZAPRINE HYDROCHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0VE05JYS2P |
| Rxcui | 828320 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-5756-0 | 2023-02-06 | C162847 | 48780-1 | f386c64a-05bb-0266-e053-dadaa90a7c1a | Cyclobenzaprine hydrochloride Tablets, USP |
| 50090-5756-1 | 2023-02-06 | C162847 | 48780-1 | f386c64a-05bb-0266-e053-dadaa90a7c1a | Cyclobenzaprine hydrochloride Tablets, USP |
| 50090-5756-2 | 2023-02-06 | C162847 | 48780-1 | f386c64a-05bb-0266-e053-dadaa90a7c1a | Cyclobenzaprine hydrochloride Tablets, USP |
| 50090-5756-3 | 2023-02-06 | C162847 | 48780-1 | f386c64a-05bb-0266-e053-dadaa90a7c1a | Cyclobenzaprine hydrochloride Tablets, USP |
| 50090-5756-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-05bb-0266-e053-dadaa90a7c1a | Cyclobenzaprine hydrochloride Tablets, USP |
| 50090-5756-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-05bb-0266-e053-dadaa90a7c1a | Cyclobenzaprine hydrochloride Tablets, USP |
| 50090-5756-2 | 2023-01-30 | C162847 | 48780-1 | f386c64a-05bb-0266-e053-dadaa90a7c1a | Cyclobenzaprine hydrochloride Tablets, USP |
| 50090-5756-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-05bb-0266-e053-dadaa90a7c1a | Cyclobenzaprine hydrochloride Tablets, USP |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5756-0 | Cyclobenzaprine hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 11 |
| 50090-5756-1 | Cyclobenzaprine hydrochloride | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | | 11 |
| 50090-5756-2 | Cyclobenzaprine hydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 11 |
| 50090-5756-3 | Cyclobenzaprine hydrochloride | 24 in 1 BOTTLE | TABLET, FILM COATED | 24 | | 11 |
| 50090-5756-4 | Cyclobenzaprine hydrochloride | 10 in 1 BOTTLE | TABLET, FILM COATED | 10 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5756 | CYCLOBENZAPRINE HYDROCHLORIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 5 package rows | 20240530_f2286776-a7de-42dc-b745-d250e741eeb6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5756-0 | 50090575600 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-5756-0) | 2021-10-01 | 0000-00-00 | No | No | Current |
| 50090-5756-1 | 50090575601 | 20 TABLET, FILM COATED in 1 BOTTLE (50090-5756-1) | 2021-10-01 | 0000-00-00 | No | No | Current |
| 50090-5756-2 | 50090575602 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5756-2) | 2021-10-01 | 0000-00-00 | No | No | Current |
| 50090-5756-3 | 50090575603 | 24 TABLET, FILM COATED in 1 BOTTLE (50090-5756-3) | 2021-11-01 | 0000-00-00 | No | No | Current |
| 50090-5756-4 | 50090575604 | 10 TABLET, FILM COATED in 1 BOTTLE (50090-5756-4) | 2024-05-17 | | No | No | Historical |